Sophia Genetics raises $30M in series D

On Sept. 12, bioinformatics company Sophia Genetics S.A. (St. Sulpice, Switzerland) raised $30 million in a series D round led by Balderton Capital. Fellow new investor 360 Capital Partners and existing investors Invoke Capital and Alychlo also participated.

Sophia markets its SOPHiA DDM software platform for the analysis of genome sequencing data. The company said the platform is used in 334 hospitals across 53 countries...